School of Human Communication Sciences, Faculty of Health Sciences, La Trobe University, Bundoora, Victoria, Australia.
Head Neck. 2010 Apr;32(4):513-28. doi: 10.1002/hed.21218.
This prospective study evaluated the impact of patient demographics, tumor characteristics, and radiotherapy treatment on swallowing before and after radiotherapy or chemoradiotherapy.
Eighty-one patients with head and neck cancer were examined using videofluoroscopy swallowing studies (VFSS) before treatment and again at 3 and 6 months after treatment.
Swallowing was best at baseline, significantly worse 3 months posttreatment, and improved by 6 months posttreatment. Worse swallowing was associated with: living in rural areas; ex-heavy alcohol consumption; hypopharyngeal tumor site; large (particularly T4) tumors; nonconformal radiotherapy; bilateral radiation to the pharynx; and longer radiotherapy fields. Through the use of multiple regression analysis, previous swallowing was determined to be the most common predictor of swallowing outcomes, followed by T classification, alcohol history, and radiotherapy technique.
The pretreatment and treatment factors that influenced swallowing in this cohort should be considered when planning treatment, in discussing potential side effects with patients, and when developing and testing future treatment techniques.
本前瞻性研究评估了患者人口统计学、肿瘤特征和放射治疗对放疗或放化疗前后吞咽的影响。
81 例头颈部癌症患者在治疗前和治疗后 3 个月和 6 个月分别进行了视频透视吞咽研究(VFSS)。
吞咽功能在基线时最佳,治疗后 3 个月显著恶化,治疗后 6 个月得到改善。更差的吞咽与以下因素有关:居住在农村地区;曾大量饮酒;下咽肿瘤部位;大肿瘤(特别是 T4 期);非适形放疗;咽双侧放疗;以及更长的放疗野。通过多元回归分析,发现治疗前的吞咽情况是吞咽结果的最常见预测因素,其次是 T 分类、饮酒史和放疗技术。
在制定治疗计划、与患者讨论潜在副作用以及开发和测试未来治疗技术时,应考虑该队列中影响吞咽的治疗前和治疗因素。